CSR Automation Guided Walkthroughs
This guided walkthrough demonstrates our end-to-end, role-based workflow. You will see firsthand how Clinion CSR Automation streamlines setup, automates content generation, and accelerates review cycles to produce submission-ready reports with unparalleled speed and accuracy.
This guided tour includes:
- Admin Setup: See how a Client Admin creates projects, manages user accounts for Authors and Reviewers, and sets up ICH E3-compliant report templates.
- AI-Powered Authoring: Watch as an Author uses the system’s Generative AI to automatically extract content from uploaded source documents like the Protocol and SAP to generate a well-structured draft.
- Collaborative Review: Discover the seamless review cycle where a Reviewer can add inline comments, view revision history, and approve sections, moving the report efficiently toward finalization.
Take CSR Automation Product Tour
Awards & Recognitions
Achievements in Clinical Excellence
Clients Testimonials
What Our Customers Say About Our Services
“ We didn’t think setting up a study in two weeks was possible until we used Clinion’s EDC. It’s intuitive, well-designed, and feels like it was built just for us. If you're looking for an innovative, robust EDC that truly supports you, this is it.
“ Clinion EDC combines a strong product with reliable support, which has been essential for our studies. It is robust and easy to navigate, with features like the visit scheduler and data loader that make our workflows better and efficient.
“ I have to say that the team and database are AMAZING!!
“ The Support team is very cooperative and available as and when required.
“ Clinion’s software is simple to configure and understand.
“ The ease and speed at which a new study can be set up in Clinion is commendable. We can set up a study within two weeks.
“ Clinion's EDC is one of easiest and quickest solution for building and configuring studies.
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%
Compliance
Fully Compliant with Global Standards
